clinical trial: phase i study of nam-nk cells immunotherapy, veronika bachanova, md phd
Published 6 years ago • 691 plays • Length 8:32Download video MP4
Download video MP3
Similar videos
-
51:08
myeloma crowd radio: veronika bachanova, md, phd, university of minnesota
-
58:44
probing the myeloma immune microenvironment one cell at a time (single-cell sequencing)
-
2:29
phase i first-in-human study of alnuctamab in patients with r/r multiple myeloma
-
1:25
are frailty scores being used in clinical trials? how?
-
59:53
clinical trials in multiple myeloma
-
1:59
dr. daisuke okuzaki - single cell analysis for human immunology research -
-
0:39
phase i/ii study of adapt-001 plus an ici for patients with immune refractory cancers
-
29:37
dr gengwen tian, nkt trial update & new immunotherapy trial opening
-
4:09
nei-labtv profile: jennifer kielczewski, laboratory of immunology
-
23:27
clinical trials
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
43:15
mcrt san diego 2020: myeloma expert panel q&a – morning session
-
1:28
early clinical trials of immunotherapy treatment combinations
-
1:56
what is a clinical trial?
-
1:57
perspectives on allogeneic nk cell-based immunotherapy
-
1:03:21
investigation of nk cell-driven tumor immunity using novel image cytometry detection method
-
4:32
understanding clinical trials
-
1:29
how do i get into a clinical trial?
-
1:10
multicenter phase ii trial evaluates adapt-001 for resistant tumors, showing promising efficacy